Interaction and dynamics of chemokine receptor CXCR4 binding with CXCL12 and hBD-3

被引:2
|
作者
Penfield, Jackson [1 ]
Zhang, Liqun [2 ]
机构
[1] Tennessee Technol Univ, Chem Engn Dept, Cookeville, TN 38505 USA
[2] Univ Rhode Isl, Chem Engn Dept, Kingston, RI 02881 USA
来源
COMMUNICATIONS CHEMISTRY | 2024年 / 7卷 / 01期
基金
美国国家卫生研究院;
关键词
CRYSTAL-STRUCTURE; HUMAN BETA-DEFENSIN-3; MOLECULAR-DYNAMICS; PROTEIN; ACTIVATION; DIMERIZATION; EXPRESSION; CANCER; DISRUPTION; MODULATION;
D O I
10.1038/s42004-024-01280-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chemokine receptor CXCR4 is involved in diverse diseases. A comparative study was conducted on CXCR4 embedded in a POPC lipid bilayer binding with CXCL12 in full and truncated forms, hBD-3 in wildtype, analog, and mutant forms based on in total 63 mu s all-atom MD simulations. The initial binding structures of CXCR4 with ligands were predicted using HADDOCK docking or random-seed method, then mu s-long simulations were performed to refine the structures. CXCR4&ligand binding structures predicted agree with available literature data. Both kinds of ligands bind stably to the N-terminus, extracellular loop 2 (ECL2), and ECL3 regions of CXCR4; the C2-C3 (K32-R38) region and occasionally the head of hBD-3 bind stably with CXCR4. hBD-3 analogs with Cys11-Cys40 disulfide bond can activate CXCR4 based on the Helix3-Helix6 distance calculation, but not other analogs or mutant. The results provide insight into understanding the dynamics and activation mechanism of CXCR4 receptor binding with different ligands. The chemokine receptor CXCR4 is involved in cancers and diverse diseases, however, molecular details surrounding the binding of different ligands to this receptor remain incomplete. Here, the authors study the binding and interaction between CXCR4 with CXCL12 and hBD-3 in different forms, and find that both ligands can bind with CXCR4 at the same site, and analogs of hBD-3 with a Cys11-Cys40 disulfide bond can activate CXCR4.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Cell surface nucleolin is crucial in the activation of the CXCL12/CXCR4 signaling pathway
    Yang, Xiangshan
    Xu, Zhongfa
    Li, Daotang
    Cheng, Shaomei
    Fan, Kaixi
    Li, Chengjun
    Li, Aiping
    Zhang, Jing
    Feng, Man
    TUMOR BIOLOGY, 2014, 35 (01) : 333 - 338
  • [32] Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
    Conley-LaComb, M. Katie
    Semaan, Louie
    Singareddy, Rajareddy
    Li, Yanfeng
    Heath, Elisabeth I.
    Kim, Seongho
    Cher, Michael L.
    Chinni, Sreenivasa R.
    MOLECULAR CANCER, 2016, 15
  • [33] The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor
    Kasina, Sathish
    Macoska, Jill A.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 351 (02) : 249 - 263
  • [34] The CXCL12/CXCR4 Signaling Axis Retains Neutrophils at Inflammatory Sites in Zebrafish
    Isles, Hannah M.
    Herman, Kimberly D.
    Robertson, Anne L.
    Loynes, Catherine A.
    Prince, Lynne R.
    Elks, Philip M.
    Renshaw, Stephen A.
    FRONTIERS IN IMMUNOLOGY, 2019, 10 : 1784
  • [35] Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways
    Drury, Luke J.
    Ziarek, Joshua J.
    Gravel, Stephanie
    Veldkamp, Christopher T.
    Takekoshi, Tomonori
    Hwang, Samuel T.
    Heveker, Nikolaus
    Volkman, Brian F.
    Dwinell, Michael B.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (43) : 17655 - 17660
  • [36] The Potent Anti-HIV Activity of CXCL12γ Correlates with Efficient CXCR4 Binding and Internalization
    Altenburg, Jeffrey D.
    Jin, Qingwen
    Alkhatib, Bashar
    Alkhatib, Ghalib
    JOURNAL OF VIROLOGY, 2010, 84 (05) : 2563 - 2572
  • [37] Elucidating a Key Component of Cancer Metastasis: CXCL12 (SDF-1α) Binding to CXCR4
    Tamamis, Phanourios
    Floudas, Christodoulos A.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2014, 54 (04) : 1174 - 1188
  • [38] Exploring the CXCR4/CXCR7/CXCL12 Axis in Primary Desmoid Tumors
    Baccalini, Edoardo Andrea
    Renne, Salvatore Lorenzo
    Colombo, Piergiuseppe
    Pasqualini, Fabio
    Quagliuolo, Vittorio Lorenzo
    Cananzi, Ferdinando Carlo Maria
    Grizzi, Fabio
    Borroni, Elena Monica
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (20) : 2248 - 2253
  • [39] Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7
    Luker, Kathryn E.
    Gupta, Mudit
    Luker, Gary D.
    BIOTECHNIQUES, 2009, 47 (01) : 625 - 632
  • [40] The Chemokine Receptors CXCR4/CXCR7 and Their Primary Heterodimeric Ligands CXCL12 and CXCL12/High Mobility Group Box 1 in Pancreatic Cancer Growth and Development Finding Flow
    Shakir, Murtaza
    Tang, Daolin
    Zeh, Herbert J.
    Tang, Siu Wah
    Anderson, Carolyn J.
    Bahary, Nathan
    Lotze, Michael T.
    PANCREAS, 2015, 44 (04) : 528 - 534